. | No nephropathy . | Nephropathy . | No retinopathy . | Retinopathy . |
---|---|---|---|---|
n | 458 | 280 | 551 | 187 |
Genotype frequency (%) | ||||
x/x, x/z+6, z+6/z+6 | 91.5/8.1/0.4 | 93.2/6.8/0 | 90.9/8.9/0.2 | 95.7/3.7/0.5* |
x/x, x/z+4, z+2/z+4 | 86.9/12.4/0.7 | 88.2/11.4/0.4 | 86.2/13.1/0.7 | 90.9/9.1/0 |
x/x, x/z+2, z+2/z+2 | 48.9/41.9/9.2 | 49.6/41.4/8.9 | 50.5/41.4/8.2 | 45.5/42.8/11.8 |
x/x, x/z, z/z | 52.0/41.9/6.1 | 50.0/40.4/9.6 | 49.7/43.0/7.3 | 55.6/36.4/8.0 |
x/x, x/z−2, z−2/z−2 | 59.8/33.8/6.3 | 59.3/34.6/6.1 | 59.9/34.3/5.8 | 58.8/33.7/7.5 |
x/x, x/z−4, z−4/z−4 | 89.1/10.9/0 | 88.2/11.8/0 | 89.8/10.2/0 | 85.6/14.4/0 |
CC, CT, TT | 65.9/28.4/5.7 | 60.4/34.3/5.4 | 65.3/29.6/5.1 | 59.4/33.7/7.0 |
Allele frequency (%) | ||||
z+6 | 4.5 | 3.4 | 4.7 | 2.5 |
z+4 | 6.9 | 6.1 | 7.3 | 4.6 |
z+2 | 30.2 | 29.7 | 28.8 | 33.1 |
Z | 27.1 | 30.0 | 28.8 | 26.2 |
z−2 | 23.3 | 23.4 | 23.0 | 24.4 |
z−4 | 5.5 | 5.9 | 5.1 | 7.2 |
X | 2.5 | 1.5 | 2.3 | 2.0 |
C | 80.1 | 77.6 | 80.1 | 76.3 |
T | 19.9 | 22.5 | 19.9 | 23.8 |
. | No nephropathy . | Nephropathy . | No retinopathy . | Retinopathy . |
---|---|---|---|---|
n | 458 | 280 | 551 | 187 |
Genotype frequency (%) | ||||
x/x, x/z+6, z+6/z+6 | 91.5/8.1/0.4 | 93.2/6.8/0 | 90.9/8.9/0.2 | 95.7/3.7/0.5* |
x/x, x/z+4, z+2/z+4 | 86.9/12.4/0.7 | 88.2/11.4/0.4 | 86.2/13.1/0.7 | 90.9/9.1/0 |
x/x, x/z+2, z+2/z+2 | 48.9/41.9/9.2 | 49.6/41.4/8.9 | 50.5/41.4/8.2 | 45.5/42.8/11.8 |
x/x, x/z, z/z | 52.0/41.9/6.1 | 50.0/40.4/9.6 | 49.7/43.0/7.3 | 55.6/36.4/8.0 |
x/x, x/z−2, z−2/z−2 | 59.8/33.8/6.3 | 59.3/34.6/6.1 | 59.9/34.3/5.8 | 58.8/33.7/7.5 |
x/x, x/z−4, z−4/z−4 | 89.1/10.9/0 | 88.2/11.8/0 | 89.8/10.2/0 | 85.6/14.4/0 |
CC, CT, TT | 65.9/28.4/5.7 | 60.4/34.3/5.4 | 65.3/29.6/5.1 | 59.4/33.7/7.0 |
Allele frequency (%) | ||||
z+6 | 4.5 | 3.4 | 4.7 | 2.5 |
z+4 | 6.9 | 6.1 | 7.3 | 4.6 |
z+2 | 30.2 | 29.7 | 28.8 | 33.1 |
Z | 27.1 | 30.0 | 28.8 | 26.2 |
z−2 | 23.3 | 23.4 | 23.0 | 24.4 |
z−4 | 5.5 | 5.9 | 5.1 | 7.2 |
X | 2.5 | 1.5 | 2.3 | 2.0 |
C | 80.1 | 77.6 | 80.1 | 76.3 |
T | 19.9 | 22.5 | 19.9 | 23.8 |
Statistically significant (P < 0.05) when the combined genotype (x/z+6 or z+6/z+6) was compared between patients with retinopathy (4.3%) and without retinopathy (9.1%). x = any other (CA)n allele.